Physician
Neonat/Perinatology
Dr. Roger Soll, MD
|
|
Give Review
Doctor Roger Soll, MD is an expert in the field of Neonat/Perinatology. He graduated from NYU School of Medicine. He has 1 awards "Fellow (FAAP)". Roger Soll is a published physician. He has 92 papers published. The most current publication "The principles and practice of evidence-based neonatology."
Publications
- Serious congenital heart disease and necrotizing enterocolitis in very low birth weight neonates.
- Randomized Trial of Occlusive Wrap for Heat Loss Prevention in Preterm Infants.
- Neuroimaging in the Evaluation of Neonatal Encephalopathy.
- Probiotic Supplementation in Preterm Infants: It Is Time to Change Practice.
- Change in Care Among Nonenrolled Patients During and After a Randomized Trial.
- Obstetric and Neonatal Care Practices for Infants 501 to 1500 g From 2000 to 2009.
- Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
- Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry.
- Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants.
- The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis.
- Surfactant for meconium aspiration syndrome in full term/near term infants.
- Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy.
- Diuretics for respiratory distress syndrome in preterm infants.
- Neonatal extracorporeal membrane oxygenation--a bridging technique.
- Surfactant for meconium aspiration syndrome in full term infants.
- Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate.
- Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
- Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory...
- Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respirator...
- Heat loss prevention in neonates.
- Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
- Appropriate surfactant usage in 1996.
- Digoxin for preventing or treating neonatal respiratory distress syndrome.
- Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
- The accuracy of the pulse oximeter in neonates.
- Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
- Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing?
- Patient-triggered ventilation of the newborn.
- Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years.
- Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
- Timing of surfactant treatment.
- Cost effectiveness of beractant in the prevention of respiratory distress syndrome.
- Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
- Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
- Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants.
- Synthetic surfactant for respiratory distress syndrome in preterm infants.
- Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
- The clinical impact of high frequency ventilation: review of the Cochrane meta-analyses.
- Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
- Inhaled nitric oxide in the neonate.
- Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome.
- Animal derived surfactant extract for treatment of respiratory distress syndrome.
- Consensus and controversy over resuscitation of the newborn infant.
- The principles and practice of evidence-based neonatology.
- Surfactant treatment of the very preterm infant.
- Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Preventio...
- Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia.
- Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
- Episodic abnormalities in transcutaneous oxygen (TcPO2) recorded during neonatal intensive care.
- Surfactant therapy in the USA: trials and current routines.
- Economic implications of neonatal intensive care unit collaborative quality improvement.
- A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome.
- Emollient ointment for preventing infection in preterm infants.
- A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
- A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Deve...
- Radiographic findings associated with surfactant treatment.
- Exogenous surfactant therapy in newborn infants.
- Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
- Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
- Topical ointment for preventing infection in preterm infants.
- Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants.
- Current surfactant use in premature infants.
- Clinical trials of natural surfactant extract in respiratory distress syndrome.
- Introduction to neonatal systematic reviews.
- Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network.
- Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy.
- Distribution of and mortality from serious congenital heart disease in very low birth weight infants.
- Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates.
- Individual patient meta-analysis in pediatrics.
- Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop.
- Evidence-based delivery room care of the very low birth weight infant.
- Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients'' data.
- Probiotics: are we ready for routine use?
- The Vermont Oxford Network: a community of practice.
- Evaluating the medical evidence for quality improvement.
- Feeding practices and patent ductus arteriosus ligation preferences-are they related?
- Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia.
- Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003.
- Current trials in the treatment of respiratory failure in preterm infants.
- What has the Cochrane collaboration ever done for newborn infants?
- Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta-analysis.
- Updating reviews: the experience of the Cochrane Neonatal Review Group.
- Cochrane neonatal systematic reviews: a survey of the evidence for neonatal therapies.
- Hypothermia and perinatal asphyxia: executive summary of the National Institute of Child Health and Human Development workshop.
- New synthetic surfactants: the next generation?
- Overview of surfactant replacement trials.
- Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial.
- Neonatal polycythemia: is partial exchange transfusion justified?
- Timing of initial surfactant treatment for infants 23 to 29 weeks'' gestation: is routine practice evidence based?
- Fetal infants: the fate of 4172 infants with birth weights of 401 to 500 grams--the Vermont Oxford Network experience (1996-2000).
- The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000 g.
Schools
Rosalind Franklin University of Medicine and Science Chicago Medical School
Nyu Bellevue Hospital Med Center
University Vt Med Center Hospital Vt
Doctors Specialties
- Neonatal Medicine
- Neonat/Perinatology
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
University of Vermont - Fletcher Allen Health Care -
NYU School of Medicine -
Rosalind Franklin University of Medicine and Science
Helpful Reviews
Similar Doctors
|
|
Dr. Robert H. Pfister, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nadine C. Seger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie K. Ardell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles E. Mercier, MD |
|
|
Dr. Marie T. Berg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon K. Evans, MD |
|
|
Dr. Anne M. Johnston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey D. Horbar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele L. Tuepker, MD |